Brief: Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC
17/04/2025 22:28
April 17 (Reuters) - Vincerx Pharma Inc VINC.O: VINCERX PHARMA, INC. ANNOUNCES INTENT TO DELIST FROM NASDAQ AND DEREGISTER WITH THE SEC VINCERX PHARMA INC - STOCK TO RESUME TRADING ON APRIL 21, 2025 VINCERX PHARMA INC - STOCK TO BE PERMANENTLY SUSPENDED ON APRIL 23, 2025 VINCERX PHARMA INC - BOARD DECIDES TO DISSOLVE, LIQUIDATE, AND WIND-UP BUSINESS Source text: ID:nGNX4qt8dT Further company coverage: VINC.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vincerx Pharma
See all newsBrief: Vincerx Pharma Announces Intent To Delist From Nasdaq And Deregister With The SEC
Brief: Vincerx Pharma Announces Termination Of Letter Of Intent And Board Authorization To Pursue Wind-Down Activities
Vincerx Pharma Inc reports results for the quarter ended December 31 - Earnings Summary
Vincerx Pharma Inc expected to post a loss of $3.40 a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Aditxt, Natgas companies, DocuSign